Feed Preview

Fast Growing

Malaria Vaccines

Malaria Vaccines diagram by Mae Melvin, Wikimedia
Mae Melvin, Wikimedia

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Top 20 most recent papers
Frontiers in Immunology

Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes

Frontiers in ImmunologyMarch 29, 2020
Chek Meng PohLeo L M Poon
European Journal of Immunology

Malaria exposure drives both cognate and bystander human B cells to adopt an atypical phenotype

European Journal of ImmunologyMarch 31, 2020
Racheal AyeFrancis M Ndungu
Accounts of Chemical Research

Syntheses of Complex Terpenes from Simple Polyprenyl Precursors

Accounts of Chemical ResearchMarch 24, 2020
Claire S Harmange MagnaniThomas J Maimone
14
PLoS Medicine

Housing and child health in sub-Saharan Africa: A cross-sectional analysis

PLoS MedicineMarch 24, 2020
Lucy S TustingSamir Bhatt
29
Phytochemistry

Plasmodium stage-selective antimalarials from Lophira lanceolata stem bark

PhytochemistryMarch 21, 2020
Harouna SoréOrazio Taglialatela-Scafati
1
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum , the Causative Agent of Neosporosis in Animals

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryMarch 28, 2020
Joachim MüllerAndrew Hemphill
Frontiers in Immunology

The Delay in the Licensing of Protozoal Vaccines: A Comparative History

Frontiers in ImmunologyMarch 27, 2020
Clarisa Beatriz Palatnik-de-Sousa, Dirlei Nico
1
The American Journal of Tropical Medicine and Hygiene

Safety Considerations for Malaria Volunteer Infection Studies: A Mini-Review

The American Journal of Tropical Medicine and HygieneMarch 20, 2020
Anand Odedra, James S McCarthy
5
Frontiers in Immunology

Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

Frontiers in ImmunologyMarch 27, 2020
Vinayaka KotraiahGabriel M Gutierrez
IDCases

Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection

IDCasesMarch 21, 2020
Christian C ConlonChristina Schofield
Evidence-based Complementary and Alternative Medicine : ECAM

A Phase II Pilot Trial to Evaluate CoBaT-Y017 Safety and Efficacy against Uncomplicated Falciparum Malaria versus Artemether-Lumefantrine in Benin Subjects

Evidence-based Complementary and Alternative Medicine : ECAMMarch 28, 2020
Adrien N NoudjiegbeAurel C E Allabi

See more papers from this feed

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

© 2020 Meta ULC. All rights reserved
/feed-previews/malaria-vaccines/44aa4521-a27f-417a-8746-5185b6dc399b